M&A Deal Summary

Euromed S.A. Acquires Probelte Biotecnología S.A

On October 9, 2017, Euromed S.A. acquired medical products company Probelte Biotecnología S.A

Acquisition Highlights
  • This is Euromed S.A.’s 1st transaction in the Medical Products sector.
  • This is Euromed S.A.’s 1st transaction in Spain.

M&A Deal Summary

Date 2017-10-09
Target Probelte Biotecnología S.A
Sector Medical Products
Buyer(s) Euromed S.A.
Deal Type Add-on Acquisition

Target

Probelte Biotecnología S.A

Murcia, Spain
Probelte Biotecnología S.A develops and manufactures ingredients for natural dietary supplements. ProbelteBio has built a strong reputation for its innovative research and development capabilities in creating marketable bio-active molecules and functional ingredients for healthy and natural dietary supplements. The company holds 10 worldwide patents for extracts developed from pomegranates and olives. It boasts its own state-of-the-art production facility, allowing for full quality control and traceability.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Euromed S.A.

Mollet del Vallès, Spain

Category Company
Founded 1971
Sector Life Science
DESCRIPTION

Euromed S.A. is a provider of herbal extracts and natural active substances for the pharmaceutical, dietary supplement and cosmetic sectors. Euromed S.A. was founded in 1971 and is based in Mollet del Vallès, Spain.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Spain M&A 1 of 1
Year: 2017 M&A 1 of 1